nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—Lactase deficiency—Entecavir—hepatitis B	0.186	0.186	CcSEcCtD
Zaleplon—Lactose intolerance—Entecavir—hepatitis B	0.186	0.186	CcSEcCtD
Zaleplon—Stiffness—Telbivudine—hepatitis B	0.0242	0.0242	CcSEcCtD
Zaleplon—Myositis—Telbivudine—hepatitis B	0.0188	0.0188	CcSEcCtD
Zaleplon—Musculoskeletal stiffness—Telbivudine—hepatitis B	0.0103	0.0103	CcSEcCtD
Zaleplon—Gingival bleeding—Lamivudine—hepatitis B	0.00913	0.00913	CcSEcCtD
Zaleplon—Anaphylactoid reaction—Entecavir—hepatitis B	0.0084	0.0084	CcSEcCtD
Zaleplon—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.00732	0.00732	CcSEcCtD
Zaleplon—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00699	0.00699	CcSEcCtD
Zaleplon—Hyperaesthesia—Lamivudine—hepatitis B	0.0066	0.0066	CcSEcCtD
Zaleplon—Migraine—Telbivudine—hepatitis B	0.00657	0.00657	CcSEcCtD
Zaleplon—Hyperglycaemia—Entecavir—hepatitis B	0.00634	0.00634	CcSEcCtD
Zaleplon—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.0062	0.0062	CcSEcCtD
Zaleplon—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00601	0.00601	CcSEcCtD
Zaleplon—Haematuria—Entecavir—hepatitis B	0.00597	0.00597	CcSEcCtD
Zaleplon—Hepatobiliary disease—Entecavir—hepatitis B	0.00592	0.00592	CcSEcCtD
Zaleplon—Gastritis—Telbivudine—hepatitis B	0.00591	0.00591	CcSEcCtD
Zaleplon—Muscular weakness—Telbivudine—hepatitis B	0.00589	0.00589	CcSEcCtD
Zaleplon—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00589	0.00589	CcSEcCtD
Zaleplon—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00583	0.00583	CcSEcCtD
Zaleplon—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00578	0.00578	CcSEcCtD
Zaleplon—Rectal haemorrhage—Lamivudine—hepatitis B	0.00574	0.00574	CcSEcCtD
Zaleplon—Oedema peripheral—Entecavir—hepatitis B	0.00554	0.00554	CcSEcCtD
Zaleplon—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00548	0.00548	CcSEcCtD
Zaleplon—Eructation—Lamivudine—hepatitis B	0.00509	0.00509	CcSEcCtD
Zaleplon—Immune system disorder—Entecavir—hepatitis B	0.00508	0.00508	CcSEcCtD
Zaleplon—Neuropathy peripheral—Telbivudine—hepatitis B	0.00504	0.00504	CcSEcCtD
Zaleplon—Alopecia—Entecavir—hepatitis B	0.00497	0.00497	CcSEcCtD
Zaleplon—Mental disorder—Entecavir—hepatitis B	0.00493	0.00493	CcSEcCtD
Zaleplon—Malnutrition—Entecavir—hepatitis B	0.00489	0.00489	CcSEcCtD
Zaleplon—Neuropathy—Lamivudine—hepatitis B	0.00487	0.00487	CcSEcCtD
Zaleplon—Photophobia—Lamivudine—hepatitis B	0.00487	0.00487	CcSEcCtD
Zaleplon—Hepatobiliary disease—Telbivudine—hepatitis B	0.00487	0.00487	CcSEcCtD
Zaleplon—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00478	0.00478	CcSEcCtD
Zaleplon—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00471	0.00471	CcSEcCtD
Zaleplon—Mouth ulceration—Lamivudine—hepatitis B	0.00469	0.00469	CcSEcCtD
Zaleplon—Back pain—Adefovir Dipivoxil—hepatitis B	0.00462	0.00462	CcSEcCtD
Zaleplon—Hypoaesthesia—Telbivudine—hepatitis B	0.0046	0.0046	CcSEcCtD
Zaleplon—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00441	0.00441	CcSEcCtD
Zaleplon—Lymphadenopathy—Lamivudine—hepatitis B	0.00441	0.00441	CcSEcCtD
Zaleplon—Gastroenteritis—Lamivudine—hepatitis B	0.00425	0.00425	CcSEcCtD
Zaleplon—Deafness—Lamivudine—hepatitis B	0.00421	0.00421	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00414	0.00414	CcSEcCtD
Zaleplon—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00407	0.00407	CcSEcCtD
Zaleplon—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00407	0.00407	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00404	0.00404	CcSEcCtD
Zaleplon—Malnutrition—Telbivudine—hepatitis B	0.00402	0.00402	CcSEcCtD
Zaleplon—Anaphylactic shock—Entecavir—hepatitis B	0.00399	0.00399	CcSEcCtD
Zaleplon—Thirst—Lamivudine—hepatitis B	0.00395	0.00395	CcSEcCtD
Zaleplon—Dysgeusia—Telbivudine—hepatitis B	0.00394	0.00394	CcSEcCtD
Zaleplon—Nervous system disorder—Entecavir—hepatitis B	0.00392	0.00392	CcSEcCtD
Zaleplon—Back pain—Telbivudine—hepatitis B	0.00389	0.00389	CcSEcCtD
Zaleplon—Skin disorder—Entecavir—hepatitis B	0.00388	0.00388	CcSEcCtD
Zaleplon—Hypoglycaemia—Lamivudine—hepatitis B	0.00386	0.00386	CcSEcCtD
Zaleplon—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00382	0.00382	CcSEcCtD
Zaleplon—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00379	0.00379	CcSEcCtD
Zaleplon—Ill-defined disorder—Telbivudine—hepatitis B	0.00373	0.00373	CcSEcCtD
Zaleplon—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00371	0.00371	CcSEcCtD
Zaleplon—Affect lability—Lamivudine—hepatitis B	0.0037	0.0037	CcSEcCtD
Zaleplon—Migraine—Lamivudine—hepatitis B	0.0037	0.0037	CcSEcCtD
Zaleplon—Malaise—Telbivudine—hepatitis B	0.00363	0.00363	CcSEcCtD
Zaleplon—Insomnia—Entecavir—hepatitis B	0.00361	0.00361	CcSEcCtD
Zaleplon—Mood swings—Lamivudine—hepatitis B	0.00356	0.00356	CcSEcCtD
Zaleplon—Somnolence—Entecavir—hepatitis B	0.00355	0.00355	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00355	0.00355	CcSEcCtD
Zaleplon—Dyspepsia—Entecavir—hepatitis B	0.00352	0.00352	CcSEcCtD
Zaleplon—Liver function test abnormal—Lamivudine—hepatitis B	0.00347	0.00347	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Entecavir—hepatitis B	0.00345	0.00345	CcSEcCtD
Zaleplon—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00343	0.00343	CcSEcCtD
Zaleplon—Arthralgia—Telbivudine—hepatitis B	0.00342	0.00342	CcSEcCtD
Zaleplon—Chest pain—Telbivudine—hepatitis B	0.00342	0.00342	CcSEcCtD
Zaleplon—Myalgia—Telbivudine—hepatitis B	0.00342	0.00342	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.0034	0.0034	CcSEcCtD
Zaleplon—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00339	0.00339	CcSEcCtD
Zaleplon—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00339	0.00339	CcSEcCtD
Zaleplon—Discomfort—Telbivudine—hepatitis B	0.00338	0.00338	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00336	0.00336	CcSEcCtD
Zaleplon—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00332	0.00332	CcSEcCtD
Zaleplon—Muscular weakness—Lamivudine—hepatitis B	0.00332	0.00332	CcSEcCtD
Zaleplon—Gastrointestinal pain—Entecavir—hepatitis B	0.00327	0.00327	CcSEcCtD
Zaleplon—Dysphagia—Lamivudine—hepatitis B	0.00325	0.00325	CcSEcCtD
Zaleplon—Nervous system disorder—Telbivudine—hepatitis B	0.00322	0.00322	CcSEcCtD
Zaleplon—Skin disorder—Telbivudine—hepatitis B	0.00319	0.00319	CcSEcCtD
Zaleplon—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00319	0.00319	CcSEcCtD
Zaleplon—Abdominal pain—Entecavir—hepatitis B	0.00316	0.00316	CcSEcCtD
Zaleplon—Body temperature increased—Entecavir—hepatitis B	0.00316	0.00316	CcSEcCtD
Zaleplon—Bronchitis—Lamivudine—hepatitis B	0.00313	0.00313	CcSEcCtD
Zaleplon—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00308	0.00308	CcSEcCtD
Zaleplon—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00308	0.00308	CcSEcCtD
Zaleplon—Dysuria—Lamivudine—hepatitis B	0.00304	0.00304	CcSEcCtD
Zaleplon—Pollakiuria—Lamivudine—hepatitis B	0.003	0.003	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00299	0.00299	CcSEcCtD
Zaleplon—Insomnia—Telbivudine—hepatitis B	0.00297	0.00297	CcSEcCtD
Zaleplon—Paraesthesia—Telbivudine—hepatitis B	0.00295	0.00295	CcSEcCtD
Zaleplon—Hyperglycaemia—Lamivudine—hepatitis B	0.00293	0.00293	CcSEcCtD
Zaleplon—Depression—Lamivudine—hepatitis B	0.00289	0.00289	CcSEcCtD
Zaleplon—Dyspepsia—Telbivudine—hepatitis B	0.00289	0.00289	CcSEcCtD
Zaleplon—Asthenia—Entecavir—hepatitis B	0.00287	0.00287	CcSEcCtD
Zaleplon—Neuropathy peripheral—Lamivudine—hepatitis B	0.00284	0.00284	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00283	0.00283	CcSEcCtD
Zaleplon—Stomatitis—Lamivudine—hepatitis B	0.00283	0.00283	CcSEcCtD
Zaleplon—Pain—Telbivudine—hepatitis B	0.00281	0.00281	CcSEcCtD
Zaleplon—Asthenia—Adefovir Dipivoxil—hepatitis B	0.0028	0.0028	CcSEcCtD
Zaleplon—Sweating—Lamivudine—hepatitis B	0.00278	0.00278	CcSEcCtD
Zaleplon—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00276	0.00276	CcSEcCtD
Zaleplon—Hepatobiliary disease—Lamivudine—hepatitis B	0.00274	0.00274	CcSEcCtD
Zaleplon—Epistaxis—Lamivudine—hepatitis B	0.00273	0.00273	CcSEcCtD
Zaleplon—Feeling abnormal—Telbivudine—hepatitis B	0.0027	0.0027	CcSEcCtD
Zaleplon—Gastrointestinal pain—Telbivudine—hepatitis B	0.00268	0.00268	CcSEcCtD
Zaleplon—Dizziness—Entecavir—hepatitis B	0.00264	0.00264	CcSEcCtD
Zaleplon—Abdominal pain—Telbivudine—hepatitis B	0.00259	0.00259	CcSEcCtD
Zaleplon—Body temperature increased—Telbivudine—hepatitis B	0.00259	0.00259	CcSEcCtD
Zaleplon—Hypoaesthesia—Lamivudine—hepatitis B	0.00259	0.00259	CcSEcCtD
Zaleplon—Rash—Entecavir—hepatitis B	0.00252	0.00252	CcSEcCtD
Zaleplon—Dermatitis—Entecavir—hepatitis B	0.00252	0.00252	CcSEcCtD
Zaleplon—Headache—Entecavir—hepatitis B	0.0025	0.0025	CcSEcCtD
Zaleplon—Rash—Adefovir Dipivoxil—hepatitis B	0.00246	0.00246	CcSEcCtD
Zaleplon—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00246	0.00246	CcSEcCtD
Zaleplon—Headache—Adefovir Dipivoxil—hepatitis B	0.00244	0.00244	CcSEcCtD
Zaleplon—Nausea—Entecavir—hepatitis B	0.00237	0.00237	CcSEcCtD
Zaleplon—Asthenia—Telbivudine—hepatitis B	0.00235	0.00235	CcSEcCtD
Zaleplon—Immune system disorder—Lamivudine—hepatitis B	0.00235	0.00235	CcSEcCtD
Zaleplon—Chills—Lamivudine—hepatitis B	0.00234	0.00234	CcSEcCtD
Zaleplon—Pruritus—Telbivudine—hepatitis B	0.00232	0.00232	CcSEcCtD
Zaleplon—Nausea—Adefovir Dipivoxil—hepatitis B	0.00231	0.00231	CcSEcCtD
Zaleplon—Alopecia—Lamivudine—hepatitis B	0.0023	0.0023	CcSEcCtD
Zaleplon—Malnutrition—Lamivudine—hepatitis B	0.00227	0.00227	CcSEcCtD
Zaleplon—Flatulence—Lamivudine—hepatitis B	0.00223	0.00223	CcSEcCtD
Zaleplon—Tension—Lamivudine—hepatitis B	0.00222	0.00222	CcSEcCtD
Zaleplon—Dysgeusia—Lamivudine—hepatitis B	0.00222	0.00222	CcSEcCtD
Zaleplon—Nervousness—Lamivudine—hepatitis B	0.0022	0.0022	CcSEcCtD
Zaleplon—Back pain—Lamivudine—hepatitis B	0.00219	0.00219	CcSEcCtD
Zaleplon—Dizziness—Telbivudine—hepatitis B	0.00217	0.00217	CcSEcCtD
Zaleplon—Tremor—Lamivudine—hepatitis B	0.00212	0.00212	CcSEcCtD
Zaleplon—Ill-defined disorder—Lamivudine—hepatitis B	0.0021	0.0021	CcSEcCtD
Zaleplon—Anaemia—Lamivudine—hepatitis B	0.00209	0.00209	CcSEcCtD
Zaleplon—Angioedema—Lamivudine—hepatitis B	0.00207	0.00207	CcSEcCtD
Zaleplon—Rash—Telbivudine—hepatitis B	0.00207	0.00207	CcSEcCtD
Zaleplon—Dermatitis—Telbivudine—hepatitis B	0.00207	0.00207	CcSEcCtD
Zaleplon—Headache—Telbivudine—hepatitis B	0.00206	0.00206	CcSEcCtD
Zaleplon—Malaise—Lamivudine—hepatitis B	0.00204	0.00204	CcSEcCtD
Zaleplon—Vertigo—Lamivudine—hepatitis B	0.00204	0.00204	CcSEcCtD
Zaleplon—Syncope—Lamivudine—hepatitis B	0.00203	0.00203	CcSEcCtD
Zaleplon—Loss of consciousness—Lamivudine—hepatitis B	0.00199	0.00199	CcSEcCtD
Zaleplon—Nausea—Telbivudine—hepatitis B	0.00195	0.00195	CcSEcCtD
Zaleplon—Myalgia—Lamivudine—hepatitis B	0.00193	0.00193	CcSEcCtD
Zaleplon—Arthralgia—Lamivudine—hepatitis B	0.00193	0.00193	CcSEcCtD
Zaleplon—Chest pain—Lamivudine—hepatitis B	0.00193	0.00193	CcSEcCtD
Zaleplon—Anxiety—Lamivudine—hepatitis B	0.00192	0.00192	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00192	0.00192	CcSEcCtD
Zaleplon—Discomfort—Lamivudine—hepatitis B	0.00191	0.00191	CcSEcCtD
Zaleplon—Dry mouth—Lamivudine—hepatitis B	0.00189	0.00189	CcSEcCtD
Zaleplon—Confusional state—Lamivudine—hepatitis B	0.00186	0.00186	CcSEcCtD
Zaleplon—Anaphylactic shock—Lamivudine—hepatitis B	0.00185	0.00185	CcSEcCtD
Zaleplon—Oedema—Lamivudine—hepatitis B	0.00185	0.00185	CcSEcCtD
Zaleplon—Shock—Lamivudine—hepatitis B	0.00182	0.00182	CcSEcCtD
Zaleplon—Nervous system disorder—Lamivudine—hepatitis B	0.00181	0.00181	CcSEcCtD
Zaleplon—Skin disorder—Lamivudine—hepatitis B	0.0018	0.0018	CcSEcCtD
Zaleplon—Hyperhidrosis—Lamivudine—hepatitis B	0.00179	0.00179	CcSEcCtD
Zaleplon—Anorexia—Lamivudine—hepatitis B	0.00176	0.00176	CcSEcCtD
Zaleplon—Hypotension—Lamivudine—hepatitis B	0.00173	0.00173	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00168	0.00168	CcSEcCtD
Zaleplon—Insomnia—Lamivudine—hepatitis B	0.00167	0.00167	CcSEcCtD
Zaleplon—Paraesthesia—Lamivudine—hepatitis B	0.00166	0.00166	CcSEcCtD
Zaleplon—Dyspnoea—Lamivudine—hepatitis B	0.00165	0.00165	CcSEcCtD
Zaleplon—Somnolence—Lamivudine—hepatitis B	0.00164	0.00164	CcSEcCtD
Zaleplon—Dyspepsia—Lamivudine—hepatitis B	0.00163	0.00163	CcSEcCtD
Zaleplon—Decreased appetite—Lamivudine—hepatitis B	0.00161	0.00161	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Lamivudine—hepatitis B	0.0016	0.0016	CcSEcCtD
Zaleplon—Pain—Lamivudine—hepatitis B	0.00158	0.00158	CcSEcCtD
Zaleplon—Constipation—Lamivudine—hepatitis B	0.00158	0.00158	CcSEcCtD
Zaleplon—Feeling abnormal—Lamivudine—hepatitis B	0.00152	0.00152	CcSEcCtD
Zaleplon—Gastrointestinal pain—Lamivudine—hepatitis B	0.00151	0.00151	CcSEcCtD
Zaleplon—Urticaria—Lamivudine—hepatitis B	0.00147	0.00147	CcSEcCtD
Zaleplon—Abdominal pain—Lamivudine—hepatitis B	0.00146	0.00146	CcSEcCtD
Zaleplon—Body temperature increased—Lamivudine—hepatitis B	0.00146	0.00146	CcSEcCtD
Zaleplon—Asthenia—Lamivudine—hepatitis B	0.00133	0.00133	CcSEcCtD
Zaleplon—Pruritus—Lamivudine—hepatitis B	0.00131	0.00131	CcSEcCtD
Zaleplon—Dizziness—Lamivudine—hepatitis B	0.00122	0.00122	CcSEcCtD
Zaleplon—Rash—Lamivudine—hepatitis B	0.00117	0.00117	CcSEcCtD
Zaleplon—Dermatitis—Lamivudine—hepatitis B	0.00116	0.00116	CcSEcCtD
Zaleplon—Headache—Lamivudine—hepatitis B	0.00116	0.00116	CcSEcCtD
Zaleplon—Nausea—Lamivudine—hepatitis B	0.0011	0.0011	CcSEcCtD
